• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms.FIP/AAPS新型/特殊剂型溶出度/体外释放度测试指南。
AAPS PharmSciTech. 2003;4(1):E7. doi: 10.1208/pt040107.
2
[The history of dosage form from the German Pharmacopoeia I to II of East Germany].[从《德国药典I》到东德《德国药典II》的剂型历史]
Pharmazie. 1984 Jul;39(7):445-61.
3
Current perspectives in dissolution testing of conventional and novel dosage forms.传统剂型与新型剂型溶出度测试的当前观点
Int J Pharm. 2007 Jan 2;328(1):12-21. doi: 10.1016/j.ijpharm.2006.10.001. Epub 2006 Oct 6.
4
[Manufacture and in vitro characterization of a new fluid theophylline sustained-release form. Sachets with microcapsules for administration in a drinkable sustained-release suspension].[一种新型液体茶碱缓释剂型的制备及其体外特性。含微胶囊的小袋，用于制成可饮用的缓释混悬液给药]
Arzneimittelforschung. 1998 May;48(5A):604-12.
5
[Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].[双氯芬酸钠缓释制剂中所选药物的技术和药物治疗特性]
Polim Med. 2012;42(2):121-32.
6
Drug formulation and biologic availability.药物制剂与生物利用度。
Semin Drug Treat. 1971 Sep;1(2):148-76.
7
[Study of the performances of Unguator mixing equipments for the pharmaceutical compounding of dermatological dosage forms].[用于皮肤科剂型药物配制剂的Unguator混合设备性能研究]
J Pharm Belg. 2006;61(1):1-10.
8
Therapeutic response in oral dosage forms.口服剂型的治疗反应。
Med Serv J Can. 1967 Mar;23(3):349-59.
9
[Advances in the field of galenics (1965 to 1967)].[盖伦制剂学领域的进展（1965年至1967年）]
Pharmazie. 1969 Feb;24(2):65-86.
10
Basics of compounding: Tips and hints: powders, capsules, tablets, suppositories, and sticks, part 1.制剂调配基础：提示与技巧：粉剂、胶囊、片剂、栓剂及棒剂，第1部分
Int J Pharm Compd. 2014 Jan-Feb;18(1):42-5.

引用本文的文献

1
Eco-friendly QbD-optimized chromatographic method for simultaneous analysis of metronidazole and nicotinamide with applications in permeation, stability, and sustainability evaluation.用于同时分析甲硝唑和烟酰胺的环保型质量源于设计（QbD）优化色谱方法及其在渗透、稳定性和可持续性评估中的应用
BMC Chem. 2025 Jul 3;19(1):195. doi: 10.1186/s13065-025-01555-6.
2
Formulation and development of paediatric orally disintegrating carbamazepine tablets.小儿用卡马西平口腔崩解片的处方设计与研发
Saudi Pharm J. 2022 Nov;30(11):1612-1622. doi: 10.1016/j.jsps.2022.09.004. Epub 2022 Sep 16.
3
Novel modified vertical diffusion cell for testing of drug release (IVRT) of topical patches.用于测试局部贴剂药物释放（体外透皮速率）的新型改良垂直扩散池
HardwareX. 2022 Mar 11;11:e00293. doi: 10.1016/j.ohx.2022.e00293. eCollection 2022 Apr.
4
Antioxidant-containing monoolein aqueous dispersions: a preliminary study.含抗氧化剂的单油酸甘油酯水基分散体：初步研究。
Drug Deliv Transl Res. 2022 Aug;12(8):1873-1880. doi: 10.1007/s13346-022-01119-4. Epub 2022 Jan 27.
5
Performance Evaluation of Montelukast Pediatric Formulations: Part I-Age-Related In Vitro Conditions.孟鲁司特儿科制剂的性能评价：第一部分——与年龄相关的体外条件。
AAPS J. 2022 Jan 10;24(1):26. doi: 10.1208/s12248-021-00661-2.
6
Cyclodextrin/Adamantane-Grafted Polyethylene Glycol-Based Self-assembling Constructs for Topical Delivery of Ketorolac Tromethamine: Formulation, Characterization, and In Vivo Studies.环糊精/金刚烷接枝聚乙二醇基自组装构建体用于酮咯酸氨丁三醇的局部递药：制剂、表征和体内研究。
AAPS PharmSciTech. 2022 Jan 3;23(1):45. doi: 10.1208/s12249-021-02188-3.
7
Optimized Taste-Masked Microparticles for Orally Disintegrating Tablets as a Promising Dosage Form for Alzheimer's Disease Patients.用于口腔崩解片的优化掩味微粒：作为阿尔茨海默病患者一种有前景的剂型
Pharmaceutics. 2021 Jul 9;13(7):1046. doi: 10.3390/pharmaceutics13071046.
8
Continuous Melt Granulation for Taste-Masking of Ibuprofen.布洛芬掩味的连续熔融造粒法
Pharmaceutics. 2021 Jun 11;13(6):863. doi: 10.3390/pharmaceutics13060863.
9
Challenges of Dissolution Methods Development for Soft Gelatin Capsules.软胶囊溶出方法开发的挑战
Pharmaceutics. 2021 Feb 4;13(2):214. doi: 10.3390/pharmaceutics13020214.
10
Physicochemical properties and formulation development of a novel compound inhibiting Staphylococcus aureus biofilm formation.新型化合物抑制金黄色葡萄球菌生物膜形成的理化性质及制剂开发。
PLoS One. 2021 Feb 8;16(2):e0246408. doi: 10.1371/journal.pone.0246408. eCollection 2021.

本文引用的文献

1
Liquefaction time of rectal suppositories.直肠栓剂的液化时间。
J Pharm Sci. 1962 Jun;51:566-71. doi: 10.1002/jps.2600510616.
2
Analysis of data on the medicament release from ointments.软膏剂药物释放数据的分析
J Pharm Sci. 1962 Aug;51:802-4. doi: 10.1002/jps.2600510825.
3
Assuring quality and performance of sustained and controlled release parenterals: workshop report.确保缓释和控释肠胃外给药制剂的质量与性能：研讨会报告
AAPS PharmSci. 2002;4(2):E7. doi: 10.1208/ps040205.
4
A short term (accelerated release) approach to evaluate peptide release from PLGA depot-formulations.一种评估从PLGA长效制剂中释放肽的短期（速释）方法。
AAPS PharmSci. 1999;1(3):E7. doi: 10.1208/ps010307.
5
Assessment of value and applications of in vitro testing of topical dermatological drug products.局部用皮肤科药品体外测试的价值评估及应用
Pharm Res. 1999 Sep;16(9):1325-30. doi: 10.1023/a:1018997520950.
6
Evaluation of the test system used for in vitro release of drugs for topical dermatological drug products.用于局部皮肤病药物产品体外释放的测试系统评估。
Pharm Dev Technol. 1999 Aug;4(3):377-85. doi: 10.1081/pdt-100101373.
7
Draft guidance for industry extended-release solid oral dosage forms. Development, evaluation and application of in vitro-in vivo correlations.工业用缓释固体口服剂型指南草案。体外-体内相关性的开发、评估和应用。
Adv Exp Med Biol. 1997;423:269-88. doi: 10.1007/978-1-4684-6036-0_25.
8
Scale-up of adhesive transdermal drug delivery systems.粘性透皮给药系统的放大研究。
Pharm Res. 1997 Jul;14(7):848-52. doi: 10.1023/a:1012135430056.
9
In-vitro dissolution profile comparison: statistics and analysis, model dependent approach.体外溶出度曲线比较：统计与分析，模型依赖方法。
Pharm Res. 1996 Dec;13(12):1799-803. doi: 10.1023/a:1016020822093.
10
In-vitro release from corticosteroid ointments.皮质类固醇软膏的体外释放
J Pharm Sci. 1995 Sep;84(9):1139-40. doi: 10.1002/jps.2600840920.

FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms.

作者信息

Siewert Martin, Dressman Jennifer, Brown Cynthia K, Shah Vinod P

机构信息

Aventis, Frankfurt, Germany.

出版信息

AAPS PharmSciTech. 2003;4(1):E7. doi: 10.1208/pt040107.

DOI:10.1208/pt040107
PMID:12916916
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2750303/
Abstract
摘要